HbA1c levels, which reflect the average plasma glucose concentration over the preceding three months, play a pivotal role in the diagnosis, assessment, and monitoring of diabetes.
HbA1c is your average blood glucose (sugar) levels for the last two to three months.
The immediate feedback of HbA1c levels is highly effective for controlling plasma glucose levels and point-of-care (POC) instruments, characterized as fast, portable, and easy-to-use, have been shown to be suitable for providing rapid feedback of HbA1c levels.
Asia Pacific is the largest consumption place, with a consumption market share nearly 50.1% in 2017. Following Asia Pacific, North America is the second largest consumption place with the consumption market share of 62.2%
According to this study, over the next five years the POC HbA1C Testing market will register a 6.4% CAGR in terms of revenue, the global market size will reach US$ 560 million by 2024, from US$ 410 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in POC HbA1C Testing business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of POC HbA1C Testing market by product type, application, key manufacturers and key regions and countries.
This study considers the POC HbA1C Testing value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Immunoassay
Boronate Affinity
Others
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Hospital & Clinics
Diagnostic Laboratories
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Abbott
Roche
Bio-Rad
Siemens
GREEN CROSS MEDIS
Trinity Biotech
HUMAN Diagnostics
PTS Diagnostics
Erba Diagnostics
EKF Diagnostics
OSANG Healthcare
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global POC HbA1C Testing consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of POC HbA1C Testing market by identifying its various subsegments.
Focuses on the key global POC HbA1C Testing manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the POC HbA1C Testing with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of POC HbA1C Testing submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
